Tegavivint for the Treatment of Relapsed or Refractory Leukemia
Clinical trial NCT04874480 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04874480
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-27
- Primary completion
- 2027-02-02
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.